P1213: SUBCUTANEOUS EPCORITAMAB WITH GEMOX INDUCED HIGH RESPONSE RATES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT
B. E. Wahlin,
J. Brody,
T. Phillips,
R. Costello,
P. Lugtenburg,
R. Cordoba,
L. Wang,
J. Wu,
B. Elliott,
A. Abbas,
J. Jørgensen
Affiliations
B. E. Wahlin
1 Karolinska Institutet, Stockholm, Sweden
J. Brody
2 Icahn School of Medicine at Mount Sinai, New York
T. Phillips
3 University of Michigan Comprehensive Cancer Center, Ann Arbor, United States of America
R. Costello
4 Assistance Publique – Hôpitaux de Marseille (AP-HM), Marseille, France
P. Lugtenburg
5 Department of Hematology, On behalf of the Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Erasmus MC Cancer Institute, Rotterdam, Netherlands
R. Cordoba
6 Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain
